Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$2.1 - $4.11 $3,914 - $7,661
1,864 Added 10.78%
19,158 $43,000
Q4 2022

Feb 08, 2023

SELL
$3.23 - $6.83 $9,131 - $19,308
-2,827 Reduced 14.05%
17,294 $58,000
Q3 2022

Oct 17, 2022

SELL
$4.95 - $11.08 $20,057 - $44,896
-4,052 Reduced 16.76%
20,121 $99,000
Q2 2022

Jul 13, 2022

BUY
$4.77 - $8.69 $190 - $347
40 Added 0.17%
24,173 $162,000
Q1 2022

May 12, 2022

BUY
$8.58 - $15.03 $1,218 - $2,134
142 Added 0.59%
24,133 $211,000
Q4 2021

Feb 03, 2022

BUY
$11.52 - $15.36 $56,931 - $75,909
4,942 Added 25.94%
23,991 $352,000
Q3 2021

Nov 02, 2021

BUY
$13.63 - $18.81 $81,561 - $112,559
5,984 Added 45.8%
19,049 $270,000
Q2 2021

Aug 10, 2021

BUY
$15.87 - $22.53 $46,388 - $65,855
2,923 Added 28.82%
13,065 $212,000
Q1 2021

May 07, 2021

SELL
$15.8 - $28.15 $35,407 - $63,084
-2,241 Reduced 18.1%
10,142 $207,000
Q4 2020

Feb 04, 2021

BUY
$9.14 - $20.08 $113,180 - $248,650
12,383 New
12,383 $196,000

Others Institutions Holding RAD

About RITE AID CORP


  • Ticker RAD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 56,535,400
  • Market Cap $9.61M
  • Description
  • Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter m...
More about RAD
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.